China Kangtai Cactus Biotech Inc. (OTCBB: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, announced today that it has developed a new technique to apply to its cactus-based cigarette product.

The company has successfully developed a new production technique for its popular cactus-based cigarette in order to further improve quality and taste and made it even more appealing for smokers. The company is adding ten percent more of its proprietary cactus material along with additional Chinese herbs to make the cigarettes less harmful.

An additional improvement in paper process technology and an improved mix of ingredients will contribute to improved quality and smell. A new filter will also reduce the amount of tar, nicotine and carbon monoxide that is inhaled.

China Kangtai CEO Jinjiang Wang said, "Cactus-based cigarettes are an exciting innovation in the Asian cigarette market. Our cactus-based cigarette already has been widely accepted by Chinese consumers. Research shows there are over 350 million cigarette smokers in China alone. To increase our penetration of this market, we are improving the taste of our product in a way that makes it even closer to the regular cigarette taste that smokers enjoy. The technology we are using represents a further breakthrough for our company and we expect our cigarette products to become even more popular among cigarette smokers."

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy drinks, wine, extracts and powders, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's high-quality "green" products are sold throughout China via a distribution network that covers 12 of China's 23 provinces and two of China's four municipalities. More information may be found at http://www.biocactus.com or via e-mail: chinakangtai@gmail.com.

China Kangtai's online investor kit, including an investment profile, press releases, current price quotes, stock charts and more is available at http://www.hawkassociates.com/profile/ckgt.cfm. To subscribe to future releases via e-mail alert, visit http://www.hawkassociates.com/about/alert/.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Hawk Associates
Frank Hawkins or Amy Lin, 305-451-1888
kangtai@hawkassociates.com